MARTIN BERT LEON
Medical Practice in Bethesda, MD
License number
Pennsylvania MD052350L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Bethesda, MD 20817
Pennsylvania
Pennsylvania
Personal information
See more information about MARTIN BERT LEON at radaris.comName
Address
Phone
413 Linden St, East Earl, PA 17519
4928 Rorer St, Philadelphia, PA 19120
1442 Church St, Reading, PA 19601
Professional information
Inhibiting Development Of Microvessels Within Coronary Or Peripheral Vessel Walls For Restenosis/Atherosclerosis Prevention Or Therapy
US Patent:
2006009, May 4, 2006
Filed:
Dec 6, 2005
Appl. No.:
11/295095
Inventors:
Stephen Epstein - Rockville MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
International Classification:
A61K 38/17, A61K 48/00
US Classification:
514012000, 514044000, 424093200
Abstract:
Disclosed and claimed are compositions and methods for therapy and/or prevention of restenosis and/or atherosclerosis. The compositions can include an agent for inhibiting VEGF and an agent for including vessel maturation; for instance, the soluble VEGF receptor and ang-1. Embodiments can include kits.
Inhibiting Development Of Microvessels Withins Coronary Or Peripheral Vessel Walls For Restenosis/Atherosclerosis Prevention Or Therapy
US Patent:
2003019, Oct 9, 2003
Filed:
Jan 5, 2000
Appl. No.:
09/478621
Inventors:
Stephen Epstein - Rockville MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
International Classification:
A61K038/17, A61K048/00
US Classification:
514/012000, 514/044000, 424/093200
Abstract:
Disclosed and claimed are compositions and methods for therapy and/or prevention of restenosis and/or atherosclerosis. The compositions can include an agent for inhibiting VEGF and an agent for inducing vessel maturation; for instance, the soluble VEGF receptor and ang-1. Embodiments can include kits.